equol has been researched along with Cognitive Decline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Butts, B; Fort, A; Garfein, J; Goon, S; Hughes, TM; Li, J; Li, M; Sekikawa, A; Veliky, CV; Wharton, W | 1 |
| Brinton, RD; Hernandez, G; Mack, WJ; Schneider, LS; Wang, Y; Yin, F | 1 |
| Igase, K; Igase, M; Kohara, K; Ohyagi, Y; Tabara, Y | 1 |
1 review(s) available for equol and Cognitive Decline
| Article | Year |
|---|---|
Potential Protective Mechanisms of S-equol, a Metabolite of Soy Isoflavone by the Gut Microbiome, on Cognitive Decline and Dementia.
Topics: Antioxidants; Cognitive Dysfunction; Dementia; Equol; Estrogen Receptor beta; Gastrointestinal Microbiome; Humans; Isoflavones; Phytoestrogens; Receptors, Estrogen | 2022 |
1 trial(s) available for equol and Cognitive Decline
| Article | Year |
|---|---|
Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy.
Topics: Apolipoproteins E; Cognition; Cognitive Dysfunction; Double-Blind Method; Equol; Feasibility Studies; Female; Genistein; Haplotypes; Hot Flashes; Humans; Isoflavones; Menopause; Middle Aged; Mitochondria; Phytoestrogens; Pilot Projects; Retrospective Studies; Selective Estrogen Receptor Modulators; Treatment Outcome | 2020 |
1 other study(ies) available for equol and Cognitive Decline
| Article | Year |
|---|---|
Cross-sectional study of equol producer status and cognitive impairment in older adults.
Topics: Aged; Cognitive Dysfunction; Cross-Sectional Studies; Equol; Female; Humans; Male; Middle Aged; Prevalence | 2017 |